CEACAM3 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-CEACAM3 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CEACAM3 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mg |
| Concentration | 1mg/ml |
| Applications | Western Blot (WB), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Western blot analysis of extracts of various cell lines, using CEACAM3 antibody. Immunohistochemical of paraffin-embedded human epididymis using CEACAM3 antibody at dilution of 1:100 (200x lens). Immunohistochemical of paraffin-embedded human lung using CEACAM3 antibody at dilution of 1:100 (400x lens). Immunohistochemistry of paraffin-embedded human testis using CEACAM3 antibody at dilution of 1:100 (200x lens). This gene encodes a member of the family of carcinoembryonic antigen-related cell adhesion molecules (CEACAMs), which are used by several bacterial pathogens to bind and invade host cells. The encoded transmembrane protein directs phagocytosis of several bacterial species that is dependent on the small GTPase Rac. It i |
| Immunogen | Immunogen: Recombinant protein of human CEACAM3 |
| Other Names | [carcinoembryonic antigen-related cell adhesion molecule 3 isoform 2; carcinoembryonic antigen-related cell adhesion molecule 3; carcinoembryonic antigen related cell adhesion molecule 3] |
| Gene, Accession # | [CEACAM3], Gene ID: 1084, NCBI: NP_001264092.1 |
| Catalog # | MBS4150133 |
| Price | $385 |
| Order / More Info | CEACAM3 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies